RxDoctor Payments Data

Thomas Ison, DO

Ophthalmology · Pikeville, KYNPI 1548290042

Payments from drug & device makers

$849in general payments, 2019–2025

Across 39 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$194
  • Harrow Eye, LLC$132
  • Mallinckrodt Hospital Products Inc.$131
  • Johnson & Johnson Surgical Vision, Inc.$104
  • Aerie Pharmaceuticals, Inc.$75
  • Amgen$43
  • plus $171 from 8 others

What the payments were for

  • Food & beverage$849100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$849 in reported general payments places this provider in the 35th percentile of 216 ophthalmology providers in Kentucky.

See all ophthalmology providers in Kentucky

Medicare billing

Part B allowed, 2024
$151,311
Medicare patients
571
Services billed
1,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine134$113,158
XiidraLifitegrast56$64,509
LumiganBimatoprost110$46,660
Cyclosporine55$24,802
Alphagan PBrimonidine Tartrate77$20,767
Prednisolone Acetate363$17,027
RocklatanNetarsudil Mesylat/Latanoprost35$15,294
RhopressaNetarsudil Mesylate32$11,728
MoxifloxacinMoxifloxacin Hcl478$11,478
Ketorolac Tromethamine552$11,110
VevyeCyclosporine14$10,390
CombiganBrimonidine Tartrate/Timolol37$8,071
Fluorometholone112$6,169
Brimonidine Tartrate143$6,133
Latanoprost665$4,925

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa$75$27,02267 claims
Harrow Eye, LLCVevye$132$10,39014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 216 ophthalmology providers in Kentucky.

Other ophthalmology in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →